Violaine Moreau

436 total citations
17 papers, 321 citations indexed

About

Violaine Moreau is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Violaine Moreau has authored 17 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in Violaine Moreau's work include Monoclonal and Polyclonal Antibodies Research (11 papers), vaccines and immunoinformatics approaches (9 papers) and RNA and protein synthesis mechanisms (4 papers). Violaine Moreau is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), vaccines and immunoinformatics approaches (9 papers) and RNA and protein synthesis mechanisms (4 papers). Violaine Moreau collaborates with scholars based in France, Iran and Brazil. Violaine Moreau's co-authors include Franck Molina, Claude Granier, Sylvie Villard, Manijeh Mahdavi, Daniel Laune, Christophe Nguyen, Daniel Laune, J. Bonnet, Sarah Guiziou and Majid Kheirollahi and has published in prestigious journals such as Nature Communications, Bioinformatics and BMC Bioinformatics.

In The Last Decade

Violaine Moreau

17 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Violaine Moreau France 11 255 156 61 54 23 17 321
Kellen Schneider India 6 186 0.7× 96 0.6× 162 2.7× 56 1.0× 39 1.7× 7 401
Lena Thoring Germany 10 416 1.6× 123 0.8× 31 0.5× 66 1.2× 8 0.3× 16 500
Denise M. O’Hara United States 12 322 1.3× 252 1.6× 167 2.7× 28 0.5× 17 0.7× 19 450
Simone Muntwiler Switzerland 8 195 0.8× 147 0.9× 130 2.1× 32 0.6× 4 0.2× 11 457
Mary Christie Australia 10 504 2.0× 73 0.5× 34 0.6× 44 0.8× 4 0.2× 21 583
С. А. Суржиков Russia 12 275 1.1× 29 0.2× 19 0.3× 51 0.9× 8 0.3× 60 446
Jee Yon Kim South Korea 7 717 2.8× 172 1.1× 34 0.6× 224 4.1× 7 0.3× 12 780
C. Shiozawa Canada 9 130 0.5× 110 0.7× 194 3.2× 23 0.4× 12 0.5× 17 344
Valérie Calabro United States 8 269 1.1× 145 0.9× 75 1.2× 30 0.6× 5 0.2× 12 353
Lisa L. Freeman-Cook United States 9 400 1.6× 27 0.2× 47 0.8× 45 0.8× 7 0.3× 10 499

Countries citing papers authored by Violaine Moreau

Since Specialization
Citations

This map shows the geographic impact of Violaine Moreau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violaine Moreau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violaine Moreau more than expected).

Fields of papers citing papers by Violaine Moreau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violaine Moreau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violaine Moreau. The network helps show where Violaine Moreau may publish in the future.

Co-authorship network of co-authors of Violaine Moreau

This figure shows the co-authorship network connecting the top 25 collaborators of Violaine Moreau. A scholar is included among the top collaborators of Violaine Moreau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violaine Moreau. Violaine Moreau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zúñiga, Ana, Sarah Guiziou, Pauline Mayonove, et al.. (2020). Rational programming of history-dependent logic in cellular populations. Nature Communications. 11(1). 4758–4758. 19 indexed citations
2.
Brevern, Alexandre G. de, Liza Felicori, Christophe Nguyen, et al.. (2019). PEPOP 2.0: new approaches to mimic non-continuous epitopes. BMC Bioinformatics. 20(1). 387–387. 9 indexed citations
3.
Brevern, Alexandre G. de, et al.. (2019). Benchmarking the PEPOP methods for mimicking discontinuous epitopes. BMC Bioinformatics. 20(1). 738–738. 4 indexed citations
4.
Guiziou, Sarah, et al.. (2018). An Automated Design Framework for Multicellular Recombinase Logic. ACS Synthetic Biology. 7(5). 1406–1412. 15 indexed citations
5.
Mahdavi, Manijeh, Violaine Moreau, & Majid Kheirollahi. (2017). Identification of B and T cell epitope based peptide vaccine from IGF-1 receptor in breast cancer. Journal of Molecular Graphics and Modelling. 75. 316–321. 16 indexed citations
6.
Mahdavi, Manijeh & Violaine Moreau. (2016). In silico designing breast cancer peptide vaccine for binding to MHC class I and II: A molecular docking study. Computational Biology and Chemistry. 65. 110–116. 20 indexed citations
7.
Keyhanfar, Mehrnaz, et al.. (2016). In silico prediction of B cell epitopes of the extracellular domain of insulin-like growth factor-1 receptor.. PubMed. 5(4). 201–214. 7 indexed citations
8.
Correa‐Basurto, José, et al.. (2015). A continuous peptide epitope reacting with pandemic influenza AH1N1 predicted by bioinformatic approaches. Journal of Molecular Recognition. 28(9). 553–564. 5 indexed citations
9.
Lebreton, Aurélien, et al.. (2014). Computer‐predicted peptides that mimic discontinuous epitopes on the A2 domain of factor VIII. Haemophilia. 21(3). e193–e201. 7 indexed citations
10.
Mahdavi, Manijeh, et al.. (2013). In silico Design of Discontinuous Peptides Representative of B and T-cell Epitopes from HER2-ECD as Potential Novel Cancer Peptide Vaccines. Asian Pacific Journal of Cancer Prevention. 14(10). 5973–5981. 10 indexed citations
11.
Lebreton, Aurélien, Violaine Moreau, Sébastien André, et al.. (2011). Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer‐designed synthetic peptides. British Journal of Haematology. 155(4). 487–497. 13 indexed citations
12.
Moura, Juliana de, Liza Felicori, Violaine Moreau, et al.. (2011). Protection against the toxic effects of Loxosceles intermedia spider venom elicited by mimotope peptides. Vaccine. 29(45). 7992–8001. 30 indexed citations
13.
Alvarenga, Larissa M., Violaine Moreau, Liza Felicori, et al.. (2009). Design of antibody-reactive peptides from discontinuous parts of scorpion toxins. Vaccine. 28(4). 970–980. 10 indexed citations
14.
Moreau, Violaine, Christophe Nguyen, Sylvie Villard, et al.. (2008). PEPOP: Computational design of immunogenic peptides. BMC Bioinformatics. 9(1). 71–71. 53 indexed citations
15.
Hancock, Mark A., et al.. (2008). TonB induces conformational changes in surface‐exposed loops of FhuA, outer membrane receptor of Escherichia coli. Protein Science. 17(10). 1679–1688. 16 indexed citations
16.
Velloso‐Rodrigues, Cibele, Violaine Moreau, Christophe Nguyen, et al.. (2008). Reactivity profile of anti‐factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains. British Journal of Haematology. 141(5). 708–715. 8 indexed citations
17.
Moreau, Violaine, Claude Granier, Sylvie Villard, Daniel Laune, & Franck Molina. (2006). Discontinuous epitope prediction based on mimotope analysis. Bioinformatics. 22(9). 1088–1095. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026